PERTH, Australia, Jan. 7, 2025 /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation...
Read More Details
Finally We wish PressBee provided you with enough information of ( Argent BioPharma Ltd. Raised US$4,500,000 )
Also on site :